sales@fnfresearch.comTel: +91 96043 17127 | USA: 1 (347) 690-0211

Search Market Research Report

Home / Category / Healthcare / Antimalarial Drugs

Antimalarial Drugs Market By Drug Class (Quinine, Chloroquine, Proguanil, Mefloquine, Pyrimethamine, and Others), and By Distribution Channel (Hospital, Pharmacy, Retail Pharmacy, E-Commerce, and Other Distribution Channel): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026

  • Publish On: Jun-2020
  • Total Pages: 178
  • Report Code: FAF-1128
  • Base Year: 2019
  • Format:

Industry Insights

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the Antimalarial Drugs industry. The report analyzes and declares the historical and current trends analysis of the Antimalarial Drugs industry and subsequently recommends the projected trends anticipated to be observed in the Antimalarial Drugs market during the upcoming years.

The Antimalarial Drugs market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entire Antimalarial Drugs market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of value (USD Million) from FY 2016 – 2026.

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the Antimalarial Drugs industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the Antimalarial Drugs industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the Antimalarial Drugs market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the Antimalarial Drugs industry. The Antimalarial Drugs market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the Antimalarial Drugs sector. Key strategic developments in the Antimalarial Drugs market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the Antimalarial Drugs market are appropriately highlighted in the report.

The Antimalarial Drugs market research report delivers an acute valuation and taxonomy of the Antimalarial Drugs industry by practically splitting the market on the basis of different types, category and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026. The regional segmentation of the Antimalarial Drugs industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Further, country-wise data for the Antimalarial Drugs industry is provided for the leading economies of the world.

Antimalarial Drugs market was accounted for approximately USD 711 Million in 2019. The market is expected to grow above a CAGR of 4.8% and is anticipated to reach over USD 1,020 Million by 2026.

The key driving factor in antimalarial drug market growth encompasses an increase in malaria prevalence in developing countries. In addition, increasing awareness of policy and increasing work on new antimalarial medicines are some of the drivers of growth on the market. However, lack of knowledge about medical care in developed countries is an important factor limiting the growth in demand for antimalarial drugs. On the other hand, emerging economies ' growth prospects are expected to present lucrative market growth prospects over the forecast period.

The Antimalarial Drugs market is segmented based on drug class, distribution channel and region. On the basis of drug class segmentation, the market is classified into Quinine, Chloroquine, Proguanil, Mefloquine, Pyrimethamine, and others. Based on distribution channel, the market is bifurcated into Hospital Pharmacy, Retail Pharmacy, E-Commerce, and Other Distribution Channel

Some of the essential players operating in the Antimalarial Drugs market, but not restricted to include GlaxoSmithKline Plc., Pfizer, Ranbaxy Laboratories, Zydus Cadila, Ipca Laboratories Ltd., Merck KGaA, Alvizia Health Care, Novartis AG, Bayer AG, Roche Incand Others.

The taxonomy of the Antimalarial Drugs industry by its scope and segmentation is as follows:

Global Antimalarial Drugs Market: By Drug Class Segmentation Analysis

  • Quinine
  • Chloroquine
  • Proguanil
  • Mefloquine
  • Pyrimethamine
  • Others

Global Antimalarial Drugs Market: By Distribution Channel Segmentation Analysis

  • Hospital Pharmacy
  • Retail Pharmacy
  • E-Commerce
  • Other Distribution Channel

Global Antimalarial Drugs Market: Regional Segmentation Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • The UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

KEY REPORT POINTERS & HIGHLIGHTS:

  • Statistically Validated Analysis of Historical, Current, and Projected Industry Trends with Authenticated Market Sizes Information and Data in terms of Value and Volume, wherever applicable
  • Direct and Indirect Factors that Impacted the Industry as well Projected Rationales expected to affect the industry going forward
  • Micro, Meso, Macro, and In-Depth Analysis of Technically relevant and Commercially viable Segments and Sub-segments of the Market
  • Historical and Projected Company / Vendor / OEM / Supplier Market Shares, Competitive Landscape, and Player Positioning Data
  • Historical and Current Demand (Consumption) and Supply (Production) Scenarios as well as Projected Supply-Demand Scenario Analysis
  • Detailed List of Key Buyers and End-Users (Consumers) analyzed as per Regions and Applications
  • Value Chain and Supply Chain Analysis along with Horizontal and Vertical Integration Scenarios
  • Manufacturing and Production Cost Structure Analysis including Labor Cost, Raw Material Expenses, and Other Manufacturing Expenses, wherever relevant
  • Overview of Key Marketing Strategies and Key Sales Channels Adopted in the Market
  • Market Attractiveness Analysis and Key Investment Opportunity Analysis in the Market going forward
  • Technological Roadmap, Patents Analysis, Potential Substitutes, and Technical Analysis
  • The professionally substantiated market research report study is calculated, constructed, and assembled by implementing a Robust Research Methodology. The Triangular Process comprises a buoyant mix of Exhaustive Primary Research (focused interviews, questionnaires, and ad-hoc surveys) and Extended Secondary Research (paid external databases, proprietary in-house database, and publically-available validated sources), where it is finally triangulated and validated through in-house industry experts, industry leaders, and independent consultants through a tri-level quality check practice.

Table of Content

  1. CHAPTER 1. Executive Summary
  2. CHAPTER 2. Antimalarial Drugs market – Drug Class Analysis
    1. 2.1. Global Antimalarial Drugs Market – Drug Class Overview
    2. 2.2. Global Antimalarial Drugs Market Share, by Drug Class, 2019 & 2026 (USD Million)
    3. 2.3. Quinine
      1. 2.3.1. Global Quinine Antimalarial Drugs Market, 2016-2026 (USD Million)
    4. 2.4. Chloroquine
      1. 2.4.1. Global Chloroquine Antimalarial Drugs Market, 2016-2026 (USD Million)
    5. 2.5. Proguanil
      1. 2.5.1. Global Proguanil Antimalarial Drugs Market, 2016-2026 (USD Million)
    6. 2.6. Mefloquine
      1. 2.6.1. Global Mefloquine Antimalarial Drugs Market, 2016-2026 (USD Million)
    7. 2.7. Pyrimethamine
      1. 2.7.1. Global Pyrimethamine Antimalarial Drugs Market, 2016-2026 (USD Million)
    8. 2.8. Others
      1. 2.8.1. Global Others Antimalarial Drugs Market, 2016-2026 (USD Million)
  3. CHAPTER 3. Antimalarial Drugs market – Distribution Channel Analysis
    1. 3.1. Global Antimalarial Drugs Market – Distribution Channel Overview
    2. 3.2. Global Antimalarial Drugs Market Share, by Distribution Channel, 2019 & 2026 (USD Million)
    3. 3.3. Hospital Pharmacy
      1. 3.3.1. Global Hospital Pharmacy Antimalarial Drugs Market, 2016-2026 (USD Million)
    4. 3.4. Retail Pharmacy
      1. 3.4.1. Global Retail Pharmacy Antimalarial Drugs Market, 2016-2026 (USD Million)
    5. 3.5. E-Commerce
      1. 3.5.1. Global E-Commerce Antimalarial Drugs Market, 2016-2026 (USD Million)
    6. 3.6. Other Distribution Channel
      1. 3.6.1. Global Other Distribution Channel Antimalarial Drugs Market, 2016-2026 (USD Million)
  4. CHAPTER 4. Antimalarial Drugs market – Regional Analysis
    1. 4.1. Global Antimalarial Drugs Market Regional Overview
    2. 4.2. Global Antimalarial Drugs Market Share, by Region, 2019 & 2026 (Value)
    3. 4.3. North America
      1. 4.3.1. North America Antimalarial Drugs Market size and forecast, 2016-2026
      2. 4.3.2. North America Antimalarial Drugs Market, by Country, 2019 & 2026 (USD Million)
      3. 4.3.3. North America Antimalarial Drugs Market, by Drug Class, 2016-2026
        1. 4.3.3.1. North America Antimalarial Drugs Market, by Drug Class, 2016-2026 (USD Million)
      4. 4.3.4. North America Antimalarial Drugs Market, by Distribution Channel, 2016-2026
        1. 4.3.4.1. North America Antimalarial Drugs Market, by Distribution Channel, 2016-2026 (USD Million)
      5. 4.3.5. U.S.
        1. 4.3.5.1. U.S. Market size and forecast, 2016-2026 (USD Million)
      6. 4.3.6. Canada
        1. 4.3.6.1. Canada Market size and forecast, 2016-2026 (USD Million)
    4. 4.4. Europe
      1. 4.4.1. Europe Antimalarial Drugs Market size and forecast, 2016-2026
      2. 4.4.2. Europe Antimalarial Drugs Market, by Country, 2019 & 2026 (USD Million)
      3. 4.4.3. Europe Antimalarial Drugs Market, by Drug Class, 2016-2026
        1. 4.4.3.1. Europe Antimalarial Drugs Market, by Drug Class, 2016-2026 (USD Million)
      4. 4.4.4. Europe Antimalarial Drugs Market, by Distribution Channel, 2016-2026
        1. 4.4.4.1. Europe Antimalarial Drugs Market, by Distribution Channel, 2016-2026 (USD Million)
      5. 4.4.5. Germany
        1. 4.4.5.1. Germany Market size and forecast, 2016-2026 (USD Million)
      6. 4.4.6. France
        1. 4.4.6.1. France Market size and forecast, 2016-2026 (USD Million)
      7. 4.4.7. U.K.
        1. 4.4.7.1. U.K. Market size and forecast, 2016-2026 (USD Million)
      8. 4.4.8. Italy
        1. 4.4.8.1. Italy Market size and forecast, 2016-2026 (USD Million)
      9. 4.4.9. Spain
        1. 4.4.9.1. Spain Market size and forecast, 2016-2026 (USD Million)
      10. 4.4.10. Rest of Europe
        1. 4.4.10.1. Rest of Europe Market size and forecast, 2016-2026 (USD Million)
    5. 4.5. Asia Pacific
      1. 4.5.1. Asia Pacific Antimalarial Drugs Market size and forecast, 2016-2026
      2. 4.5.2. Asia Pacific Antimalarial Drugs Market, by Country, 2019 & 2026 (USD Million)
      3. 4.5.3. Asia Pacific Antimalarial Drugs Market, by Drug Class, 2016-2026
        1. 4.5.3.1. Asia Pacific Antimalarial Drugs Market, by Drug Class, 2016-2026 (USD Million)
      4. 4.5.4. Asia Pacific Antimalarial Drugs Market, by Distribution Channel, 2016-2026
        1. 4.5.4.1. Asia Pacific Antimalarial Drugs Market, by Distribution Channel, 2016-2026 (USD Million)
      5. 4.5.5. China
        1. 4.5.5.1. China Market size and forecast, 2016-2026 (USD Million)
      6. 4.5.6. Japan
        1. 4.5.6.1. Japan Market size and forecast, 2016-2026 (USD Million)
      7. 4.5.7. India
        1. 4.5.7.1. India Market size and forecast, 2016-2026 (USD Million)
      8. 4.5.8. South Korea
        1. 4.5.8.1. South Korea Market size and forecast, 2016-2026 (USD Million)
      9. 4.5.9. South-East Asia
        1. 4.5.9.1. South-East Asia Market size and forecast, 2016-2026 (USD Million)
      10. 4.5.10. Rest of Asia Pacific
        1. 4.5.10.1. Rest of Asia Pacific Market size and forecast, 2016-2026 (USD Million)
    6. 4.6. Latin America
      1. 4.6.1. Latin America Antimalarial Drugs Market size and forecast, 2016-2026
      2. 4.6.2. Latin America Antimalarial Drugs Market, by Country, 2019 & 2026 (USD Million)
      3. 4.6.3. Latin America Antimalarial Drugs Market, by Drug Class, 2016-2026
        1. 4.6.3.1. Latin America Antimalarial Drugs Market, by Drug Class, 2016-2026 (USD Million)
      4. 4.6.4. Latin America Antimalarial Drugs Market, by Distribution Channel, 2016-2026
        1. 4.6.4.1. Latin America Antimalarial Drugs Market, by Distribution Channel, 2016-2026 (USD Million)
      5. 4.6.5. Brazil
        1. 4.6.5.1. Brazil Market size and forecast, 2016-2026 (USD Million)
      6. 4.6.6. Mexico
        1. 4.6.6.1. Mexico Market size and forecast, 2016-2026 (USD Million)
      7. 4.6.7. Rest of Latin America
        1. 4.6.7.1. Rest of Latin America Market size and forecast, 2016-2026 (USD Million)
    7. 4.7. The Middle-East and Africa
      1. 4.7.1. The Middle-East and Africa Antimalarial Drugs Market size and forecast, 2016-2026
      2. 4.7.2. The Middle-East and Africa Antimalarial Drugs Market, by Country, 2019 & 2026 (USD Million)
      3. 4.7.3. The Middle-East and Africa Antimalarial Drugs Market, by Drug Class, 2016-2026
        1. 4.7.3.1. The Middle-East and Africa Antimalarial Drugs Market, by Drug Class, 2016-2026 (USD Million)
      4. 4.7.4. The Middle-East and Africa Antimalarial Drugs Market, by Distribution Channel, 2016-2026
        1. 4.7.4.1. The Middle-East and Africa Antimalarial Drugs Market, by Distribution Channel, 2016-2026 (USD Million)
      5. 4.7.5. GCC Countries
        1. 4.7.5.1. GCC Countries Market size and forecast, 2016-2026 (USD Million)
      6. 4.7.6. South Africa
        1. 4.7.6.1. South Africa Market size and forecast, 2016-2026 (USD Million)
      7. 4.7.7. Rest of Middle-East Africa
        1. 4.7.7.1. Rest of Middle-East Africa Market size and forecast, 2016-2026 (USD Million)
  5. CHAPTER 5. Antimalarial Drugs market – Competitive Landscape
    1. 5.1. Competitor Market Share – Revenue
    2. 5.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    3. 5.3. Strategic Development
      1. 5.3.1. Acquisitions and Mergers
      2. 5.3.2. New Products
      3. 5.3.3. Research & Development Activities
  6. CHAPTER 6. Company Profiles
    1. 6.1. GlaxoSmithKline Plc.
      1. 6.1.1. Company Overview
      2. 6.1.2. GlaxoSmithKline Plc. Revenue and Gross Margin
      3. 6.1.3. Product portfolio
      4. 6.1.4. Recent initiatives
    2. 6.2. Pfizer
      1. 6.2.1. Company Overview
      2. 6.2.2. Pfizer Revenue and Gross Margin
      3. 6.2.3. Product portfolio
      4. 6.2.4. Recent initiatives
    3. 6.3. Ranbaxy Laboratories
      1. 6.3.1. Company Overview
      2. 6.3.2. Ranbaxy Laboratories Revenue and Gross Margin
      3. 6.3.3. Product portfolio
      4. 6.3.4. Recent initiatives
    4. 6.4. Zydus Cadila
      1. 6.4.1. Company Overview
      2. 6.4.2. Zydus Cadila Revenue and Gross Margin
      3. 6.4.3. Product portfolio
      4. 6.4.4. Recent initiatives
    5. 6.5. Ipca Laboratories Ltd.
      1. 6.5.1. Company Overview
      2. 6.5.2. Ipca Laboratories Ltd. Revenue and Gross Margin
      3. 6.5.3. Product portfolio
      4. 6.5.4. Recent initiatives
    6. 6.6. Merck KGaA
      1. 6.6.1. Company Overview
      2. 6.6.2. Merck KGaA Revenue and Gross Margin
      3. 6.6.3. Product portfolio
      4. 6.6.4. Recent initiatives
    7. 6.7. Alvizia Health Care
      1. 6.7.1. Company Overview
      2. 6.7.2. Alvizia Health Care Revenue and Gross Margin
      3. 6.7.3. Product portfolio
      4. 6.7.4. Recent initiatives
    8. 6.8. Novartis AG
      1. 6.8.1. Company Overview
      2. 6.8.2. Novartis AG Revenue and Gross Margin
      3. 6.8.3. Product portfolio
      4. 6.8.4. Recent initiatives
    9. 6.9. Bayer AG
      1. 6.9.1. Company Overview
      2. 6.9.2. Bayer AG Revenue and Gross Margin
      3. 6.9.3. Product portfolio
      4. 6.9.4. Recent initiatives
    10. 6.10. Roche Inc.
      1. 6.10.1. Company Overview
      2. 6.10.2. Roche Inc. Revenue and Gross Margin
      3. 6.10.3. Product portfolio
      4. 6.10.4. Recent initiatives
  7. CHAPTER 7. Antimalarial Drugs — Industry Analysis
    1. 7.1. Antimalarial Drugs Market – Key Trends
      1. 7.1.1. Market Drivers
      2. 7.1.2. Market Restraints
      3. 7.1.3. Market Opportunities
    2. 7.2. Value Chain Analysis
    3. 7.3. Technology Roadmap and Timeline
    4. 7.4. Antimalarial Drugs Market – Attractiveness Analysis
      1. 7.4.1. By Drug Class
      2. 7.4.2. By Distribution Channel
      3. 7.4.3. By Region
  8. CHAPTER 8. Marketing Strategy Analysis, Distributors
    1. 8.1. Marketing Channel
    2. 8.2. Direct Marketing
    3. 8.3. Indirect Marketing
    4. 8.4. Marketing Channel Development Trend
    5. 8.5. Economic/Political Environmental Change
  9. CHAPTER 9. Report Conclusion
  10. CHAPTER 10. Research Approach & Methodology
    1. 10.1. Report Description
    2. 10.2. Research Scope
    3. 10.3. Research Methodology
      1. 10.3.1. Secondary Research
      2. 10.3.2. Primary Research
      3. 10.3.3. Models
        1. 10.3.3.1. Company Share Analysis Model
        2. 10.3.3.2. Revenue Based Modeling
        3. 10.3.3.3. Research Limitations

        List of Figures

        FIG. 1 Global Antimalarial Drugs Market, 2016-2026 (USD Million)
        FIG. 2 Global Antimalarial Drugs Market Share, by Drug Class, 2019 & 2026 (USD Million)
        FIG. 3 Global Quinine Antimalarial Drugs Market, 2016-2026 (USD Million)
        FIG. 4 Global Chloroquine Antimalarial Drugs Market, 2016-2026 (USD Million)
        FIG. 5 Global Proguanil Antimalarial Drugs Market, 2016-2026 (USD Million)
        FIG. 6 Global Mefloquine Antimalarial Drugs Market, 2016-2026 (USD Million)
        FIG. 7 Global Pyrimethamine Antimalarial Drugs Market, 2016-2026 (USD Million)
        FIG. 8 Global Others Antimalarial Drugs Market, 2016-2026 (USD Million)
        FIG. 9 Global Antimalarial Drugs Market Share, by Distribution Channel, 2019 & 2026 (USD Million)
        FIG. 10 Global Hospital Pharmacy Antimalarial Drugs Market, 2016-2026 (USD Million)
        FIG. 11 Global Retail Pharmacy Antimalarial Drugs Market, 2016-2026 (USD Million)
        FIG. 12 Global E-Commerce Antimalarial Drugs Market, 2016-2026 (USD Million)
        FIG. 13 Global Other Distribution Channel Antimalarial Drugs Market, 2016-2026 (USD Million)
        FIG. 14 Global Antimalarial Drugs Market Share, by Region, 2019 & 2026
        FIG. 15 North America Antimalarial Drugs Market, 2016-2026
        FIG. 16 U.S. Antimalarial Drugs Market, 2016-2026
        FIG. 17 Canada Antimalarial Drugs Market, 2016-2026
        FIG. 18 Europe Antimalarial Drugs Market, 2016-2026
        FIG. 19 Germany Antimalarial Drugs Market, 2016-2026
        FIG. 20 France Antimalarial Drugs Market, 2016-2026
        FIG. 21 U.K. Antimalarial Drugs Market, 2016-2026
        FIG. 22 Italy Antimalarial Drugs Market, 2016-2026
        FIG. 23 Spain Antimalarial Drugs Market, 2016-2026
        FIG. 24 Rest of Europe Antimalarial Drugs Market, 2016-2026
        FIG. 25 Asia Pacific Antimalarial Drugs Market, 2016-2026
        FIG. 26 China Antimalarial Drugs Market, 2016-2026
        FIG. 27 Japan Antimalarial Drugs Market, 2016-2026
        FIG. 28 India Antimalarial Drugs Market, 2016-2026
        FIG. 29 South  Korea Antimalarial Drugs Market, 2016-2026
        FIG. 30 South-East Asia Antimalarial Drugs Market, 2016-2026
        FIG. 31 Rest of Asia Pacific Antimalarial Drugs Market, 2016-2026
        FIG. 32 Latin America Antimalarial Drugs Market, 2016-2026
        FIG. 33 Brazil Antimalarial Drugs Market, 2016-2026
        FIG. 34 Mexico Antimalarial Drugs Market, 2016-2026
        FIG. 35 Rest of Latin America Antimalarial Drugs Market, 2016-2026
        FIG. 36 The Middle-East and Africa Antimalarial Drugs Market, 2016-2026
        FIG. 37 GCC Countries Antimalarial Drugs Market, 2016-2026
        FIG. 38 South Africa Antimalarial Drugs Market, 2016-2026
        FIG. 39 Rest of Middle-East Africa Antimalarial Drugs Market, 2016-2026
        FIG. 40 Competitor Market Share – Revenue
        FIG. 41 GlaxoSmithKline Plc. Revenue and Growth Rate
        FIG. 42 GlaxoSmithKline Plc. Market Share
        FIG. 43 Pfizer Revenue and Growth Rate
        FIG. 44 Pfizer Market Share
        FIG. 45 Ranbaxy Laboratories Revenue and Growth Rate
        FIG. 46 Ranbaxy Laboratories Market Share
        FIG. 47 Zydus Cadila Revenue and Growth Rate
        FIG. 48 Zydus Cadila Market Share
        FIG. 49 Ipca Laboratories Ltd. Revenue and Growth Rate
        FIG. 50 Ipca Laboratories Ltd. Market Share
        FIG. 51 Merck KGaA Revenue and Growth Rate
        FIG. 52 Merck KGaA Market Share
        FIG. 53 Alvizia Health Care Revenue and Growth Rate
        FIG. 54 Alvizia Health Care Market Share
        FIG. 55 Novartis AG Revenue and Growth Rate
        FIG. 56 Novartis AG Market Share
        FIG. 57 Bayer AG Revenue and Growth Rate
        FIG. 58 Bayer AG Market Share
        FIG. 59 Roche Inc. Revenue and Growth Rate
        FIG. 60 Roche Inc. Market Share
        FIG. 61 Market Dynamics
        FIG. 62 Global Antimalarial Drugs – Value Chain Analysis
        FIG. 63 Technology Roadmap and Timeline
        FIG. 64 Market Attractiveness Analysis – By Drug Class
        FIG. 65 Market Attractiveness Analysis – By Distribution Channel
        FIG. 66 Market Attractiveness Analysis – By Region
        FIG. 67 Market Channel
        FIG. 68 Marketing Channel Development Trend
        FIG. 69 Growth in World Gross Product, 2008-2019

        List of Tables

        TABLE 1 Global Antimalarial Drugs Market, 2019 & 2026 (USD Million)
        TABLE 2 Global Antimalarial Drugs market, by Drug Class, 2016-2026 (USD Million)
        TABLE 3 Global Antimalarial Drugs market, by Distribution Channel, 2016-2026 (USD Million)
        TABLE 4 Global Antimalarial Drugs market, by Region, 2016-2026 (USD Million)
        TABLE 5 North America Antimalarial Drugs Market, by Drug Class, 2016-2026 (USD Million)
        TABLE 6 North America Antimalarial Drugs Market, by Distribution Channel, 2016-2026 (USD Million)
        TABLE 7 Europe Antimalarial Drugs Market, by Drug Class, 2016-2026 (USD Million)
        TABLE 8 Europe Antimalarial Drugs Market, by Distribution Channel, 2016-2026 (USD Million)
        TABLE 9 Asia Pacific Antimalarial Drugs Market, by Drug Class, 2016-2026 (USD Million)
        TABLE 10 Asia Pacific Antimalarial Drugs Market, by Distribution Channel, 2016-2026 (USD Million)
        TABLE 11 Latin America Antimalarial Drugs Market, by Drug Class, 2016-2026 (USD Million)
        TABLE 12 Latin America Antimalarial Drugs Market, by Distribution Channel, 2016-2026 (USD Million)
        TABLE 13 The Middle-East and Africa Antimalarial Drugs Market, by Drug Class, 2016-2026 (USD Million)
        TABLE 14 The Middle-East and Africa Antimalarial Drugs Market, by Distribution Channel, 2016-2026 (USD Million)
        TABLE 15 Global Antimalarial Drugs Market - Company Revenue Analysis 2016-2019 (USD Million)
        TABLE 16 Global Antimalarial Drugs Market - Company Revenue Share Analysis 2016-2019(%)
        TABLE 17 Acquisitions and Mergers
        TABLE 18 New Product/Service Launch
        TABLE 19 Research & Development Activities
        TABLE 20 Market Drivers
        TABLE 21 Market Restraints
        TABLE 22 Market Opportunities

Key Insights from Primary Research

  • According to the primary CXO’s of the global Antimalarial Drugs market, the market is estimated to witness a substantial growth of nearly 4.8% over the forecast period.
  • The market was valued at USD 711 million, in 2019 and is expected to be valued over USD 1,020 million.
  • On the basis of the drug class segment, Chloroquine dominated the global Antimalarial Drugs market in 2019. In terms of revenue, it accounted for more than a 27% share of the total market in 2019.
  • Asia Pacific market is expected to be the fastest goring region for Antimalarial Drugs over the forecast period owing to growing investments for R&D and pharmaceuticals companies in the region.
  • By geography, the North America region headed the market with a share of above 33%, in 2019.

Key Recommendations from Analysts

  • Higher prevalence of malaria cases, technological advances, high unmet medical needs and government initiatives are major factors that are expected to drive the development of the treatment market for malaria in the near future.
  • The strategic developments such as regional expansion, product innovations and on-going research and developments by the major companies such as G GlaxoSmithKline Plc., Pfizer, Ranbaxy Laboratories, Zydus Cadila, etc. is likely to boom the market’s growth over the up-coming years.
  • Our analysts recommend that the Asia Pacific region is predicted to witness a significant growth attributed to the growing demand for Antimalarial Drugs from China and India.
  • Expansion of pharmaceuticals companies especially in emerging market is antipicated to fuel the demand for Antimalarial Drugs drug in the developing regions over the forthcoming years.
  • Strengthening the distribution channel and growing availability of bipolar disorder drugs online may also help the major player to cater the lucrative growth of the market over the years to come.

Market Share Analysis by Region

Industry Major Market Players

  • GlaxoSmithKline Plc.
  • Pfizer
  • Ranbaxy Laboratories
  • Zydus Cadila
  • Ipca Laboratories Ltd.
  • Merck KGaA
  • Alvizia Health Care
  • Novartis AG
  • Bayer AG
  • Roche Incand 

Related Reports

Cone Beam Computed Tomography (CBCT) Market By Application (Dental Applications, Implantology, Oral and Maxillofacial Surgery, Orthodontics, Endodontics, General Dentistry, Temporomandibular Joint (TMJ) Disorders, Periodontics, Forensic Dentistry and Other Applications) By patient Position (Standing/Seated, Seated and Supine) For Hospitals, Clinics and Research Institutes: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2026

This specializedexpertise oriented industry research report scrutinizes the technical and commercial business outlook of the Cone beam computed tomography (CBCT) industry. The report analyzes and declares the historical and current trends analysis of the Cone beam computed tomography (CBCT) indust...Read More

Sep-2020 | Price : $ 3850.00 | Pages: 190 | Report Code: ZMR-1311 | Report Format:

Plasma Therapy Market Type (Pure PRP, Leucocyte-Rich PRP, Pure Platelet-Rich Fibrin, Leukocyte-Rich Fibrin), Source (Autologous, Allogenic), Application (Orthopedics, Dermatology, Dental, Cardiac Muscle Injury, Nerve Injury, Others), End User (Hospitals & Clinics, Research Institutions): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2026

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the Plasma Therapy industry. The report analyzes and declares the historical and current trends analysis of the Plasma Therapy industry and subsequently recommends the proj...Read More

Sep-2020 | Price : $ 3850.00 | Pages: 130 | Report Code: ZMR-1279 | Report Format:

Pneumonia Therapeutics Market by Product Type (Drugs (Branded and Generics), Vaccines, and Oxygen Therapy), and Regions: Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026

This specializedandexpertise oriented industry research report scrutinizes the technical and commercial business outlook of the pneumonia therapeutics industry. The report analyzes and declares the historical and current trends analysis of the pneumonia therapeutics industry and subsequently recom...Read More

Sep-2020 | Price : $ 3850.00 | Pages: 190 | Report Code: ZMR-1271 | Report Format:

Safe and Secure SSL Encrypted

Choose License Type

Inquiry For Buying

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

have a question

HAVE A QUESTION? Executive will help you find what you are looking for.


REQUEST CUSTOMIZATION

Still haven't found what you're looking for? Speak to our Custom Research Team

Learn More
Facts & Factors provides an array of marketing and business research solutions distinctly designed by our expertise for the clients.
Copyright © 2020 Facts & Factors. All Rights Reserved. Sitemap - Privacy Policy - Terms & Conditions